Analysis of the US Clinical Laboratories Market

Decentralization will Significantly Increase Retail Setting Test Volume by 2017
Share this:
     
Published: 22 Oct 2015

This research service evaluates the US clinical laboratories market. The analysis provides extensive understanding of test distribution in independent laboratories (reference and specialized), physician office laboratories, hospital-based labs, and others including retail clinics and mobile diagnostic centers. The study covers the potential impact of the Food and Drug Administration’s laboratory-developed test (LDT) regulation guideline on clinical laboratories and the effects of the physician fee schedules (PFS) and clinical laboratory fee schedules (CLFS) on the price of tests. Key companies to watch for high-complexity testing and home health monitoring have been assessed. The study period is from 2012 to 2018; the base year is 2014.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..